Jump to main content
Jump to site search

Issue 47, 2007
Previous Article Next Article

Carboranyl thymidine analogues for neutron capture therapy

Author affiliations

Abstract

Neutron capture therapy (NCT) is a binary radio-chemotherapeutic modality for the treatment of cancer. A major focus of NCT-related research is the development of novel tumor-selective agents that serve as the chemical component in NCT. Thymidine analogues substituted with a boron-containing carborane cluster at the N3 position, designated 3CTAs (3-carboranyl thymidine analogues), constitute one class of these new improved NCT agents. Their chemical, structural and biological properties are discussed in this Feature Article.

Graphical abstract: Carboranyl thymidine analogues for neutron capture therapy

Back to tab navigation

Publication details

The article was received on 14 May 2007, accepted on 17 Jul 2007 and first published on 15 Aug 2007


Article type: Feature Article
DOI: 10.1039/B707257K
Citation: Chem. Commun., 2007,0, 4978-4991
  •   Request permissions

    Carboranyl thymidine analogues for neutron capture therapy

    W. Tjarks, R. Tiwari, Y. Byun, S. Narayanasamy and Rolf. F. Barth, Chem. Commun., 2007, 0, 4978
    DOI: 10.1039/B707257K

Search articles by author

Spotlight

Advertisements